4081 Baculovirus p35 protein-related
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Organic oxygen compounds | 12 | 5.1 | 2.35× | q = 4.5e-3 | |
| Homogeneous non-metal compounds | 5 | 5.5 | 0.91× | q = 1.00 | |
| Homogeneous metal compounds | 7 | 12.6 | 0.56× | q = 0.05 | |
| Nucleosides, nucleotides, and analogues | 0 | 7.1 | 0 | q = 1.4e-3 | |
| Phenylpropanoids and polyketides | 4 | 0.5 | 7.50× | not tested | |
| Organic nitrogen compounds | 5 | 0.8 | 6.11× | not tested | |
| Organic acids and derivatives | 16 | 4.0 | 4.03× | not tested | |
| Benzenoids | 5 | 1.9 | 2.67× | not tested | |
| Organoheterocyclic compounds | 4 | 4.0 | 1.01× | not tested | |
| Lipids and lipid-like molecules | 1 | 2.9 | 0.35× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 121 |
| DB03424 | BES | Ubenimex | 20 |
| DB00123 | LYS | Lysine | 7 |
| DB00125 | ARG | Arginine | 7 |
| DB00142 | GLU | Glutamic acid | 6 |
| DB00128 | ASP | Aspartic acid | 5 |
| DB00135 | TYR | Tyrosine | 5 |
| DB00149 | LEU | Leucine | 5 |
| DB00134 | MET | Methionine | 4 |
| DB00150 | TRP | Tryptophan | 3 |
| DB00160 | ALA | Alanine | 3 |
| DB04447 | DTT | 1,4-Dithiothreitol | 3 |
| DB00120 | PHE | Phenylalanine | 2 |
| DB03817 | DAB | L-2,4-diaminobutyric acid | 2 |
| DB06851 | 11X | N-(pyridin-3-ylmethyl)aniline | 2 |
| DB08466 | RE2 | 5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol | 2 |
| DB11781 | — | — | 2 |
| DB00133 | SER | Serine | 1 |
| DB00143 | GSH | Glutathione | 1 |
| DB00145 | GLY | Glycine | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 80 |
| NAmetal | SODIUM ION | 45 |
| YBmetal | YTTERBIUM (III) ION | 45 |
| MGmetal | MAGNESIUM ION | 43 |
| BES | 2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID | 24 |
| P52 | Nalpha-[(2S)-2-{[[(1R)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]methyl}-4-methylpentanoyl]-L-tryptophanamide | 24 |
| LYS | LYSINE | 9 |
| CL | CHLORIDE ION | 7 |
| ARG | ARGININE | 6 |
| 28T | 1-{4-oxo-4-[(2S)-pyrrolidin-2-yl]butanoyl}-L-proline | 5 |
| DJ3 | 5S-5,6-oxido-7,9-trans-11,14-cis-eicosatetraenoic acid | 5 |
| GLU | GLUTAMIC ACID | 5 |
| LEU | LEUCINE | 5 |
| MET | METHIONINE | 5 |
| N0Y | 1-benzyl-4-methoxybenzene | 5 |
| TYR | TYROSINE | 5 |
| ASP | ASPARTIC ACID | 4 |
| ALA | ALANINE | 3 |
| BR | BROMIDE ION | 3 |
| CAmetal | CALCIUM ION | 3 |